Kim Sablich

Kim Sablich

No más puestos en curso
57 años
Health Technology
Consumer Services
Technology Services

Perfil

Kim Sablich formerly worked at Eiger BioPharmaceuticals, Inc., as Independent Director from 2021 to 2024, AllerGenis LLC, as Director from 2018 to 2021, GSK Plc, as Vice President from 2015 to 2018, Jazz Pharmaceuticals Plc, as Executive VP & General Manager-North America from 2020 to 2023, Myovant Sciences, Inc., as Chief Commercial Officer from 2018 to 2020, and Myovant Sciences Ltd., as Chief Commercial Officer from 2018 to 2020.
Ms. Sablich received her undergraduate degree from Denison University and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.

Antiguos cargos conocidos de Kim Sablich.

EmpresasCargoFin
EIGER BIOPHARMACEUTICALS Director/Miembro de la Junta 01/09/2024
JAZZ PHARMACEUTICALS PLC Corporate Officer/Principal 31/12/2023
Director/Miembro de la Junta 01/04/2021
MYOVANT SCIENCES LTD. Corporate Officer/Principal 11/05/2020
Corporate Officer/Principal 01/05/2020
Ver el detalle de la experiencia de Kim Sablich.

Formación de Kim Sablich.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

65

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Technology Services